Literature DB >> 25987965

Advanced glycation end-product expression is upregulated in the gastrointestinal tract of type 2 diabetic rats.

Peng-Min Chen1, Hans Gregersen1, Jing-Bo Zhao1.   

Abstract

AIM: To investigate changes in advanced glycation end products (AGEs) and their receptor (RAGE) expression in the gastrointestinal (GI) tract in type 2 diabetic rats.
METHODS: Eight inherited type 2 diabetic rats Goto-Kakizak (GK) and ten age-matched normal rats were used in the study. From 18 wk of age, the body weight and blood glucose were measured every week and 2 wk respectively. When the rats reached 32 wk, two-centimeter segments of esophagus, duodenum, jejunum, ileum, and colon were excised and the wet weight was measured. The segments were fixed in 10% formalin, embedded in paraffin and five micron sections were cut. The layer thickness was measured in Hematoxylin and Eosin-stained slides. AGE [N epsilon-(carboxymethyl) lysine and N epsilon-(carboxyethyl)lysine] and RAGE were detected by immunohistochemistry staining and image analysis was done using Sigmascan Pro 4.0 image analysis software.
RESULTS: The blood glucose concentration (mmol/L) at 18 wk age was highest in the GK group (8.88 ± 1.87 vs 6.90 ± 0.43, P < 0.001), a difference that continued to exist until the end of the experiment. The wet weight per unit length (mg/cm) increased in esophagus, jejunum and colon from the normal to the GK group (60.64 ± 9.96 vs 68.56 ± 11.69, P < 0.05 for esophagus; 87.01 ± 9.35 vs 105.29 ± 15.45, P < 0.01 for jejunum; 91.37 ± 7.25 vs 97.28 ± 10.90, P < 0.05 for colon). Histologically, the layer thickness of the GI tract was higher for esophagus, jejunum and colon in the GK group [full thickness (μm): 575.37 ± 69.22 vs 753.20 ± 150.41, P < 0.01 for esophagus; 813.51 ± 44.44 vs 884.81 ± 45.31, P < 0.05 for jejunum; 467.12 ± 65.92 vs 572.26 ± 93.60, P < 0.05 for colon]. In esophagus, the AGE and RAGE mainly distributed in striated muscle cells and squamous epithelial cells. The AGE distribution was much stronger in the GK group compared to the normal group both in the striated muscle layer and mucosa layer (immuno-positive area/ total measuring area %: 4.52 ± 0.89 vs 10.96 ± 1.34, P < 0.01 for muscle; 8.90 ± 2.62 vs 22.45 ± 1.26, P < 0.01 for mucosa). No visible difference was found for RAGE distribution between the two groups. In the intestine AGE and RAGE distributed in epithelial cells of villi and crypt. RAGE was also found in neurons in the myenteric and submucosal plexus. The intensity of AGE staining in mucosa of all segments and RAGE staining in neurons in all segments were strongest in the diabetes group. Significant difference for AGE was found in the epithelial cells of villi and crypt in duodenum (immuno-positive area/total measuring area %: 13.37 ± 3.51 vs 37.48 ± 8.43, P < 0.05 for villi; 0.38 ± 0.12 vs 1.87 ± 0.53, P < 0.05 for crypt) and for RAGE in neurons of all segments (e.g., for jejunum: no staining neurons% 0 vs 0, mild 36.0 ± 5.2 vs 28.7 ± 3.5, moderate 53.2 ± 4.8 vs 55.8 ± 5.4, strong 10.7 ± 1.1 vs 15.4 ± 2.0, P < 0.05). In the colon, RAGE was primarily found in neurons in the myenteric and submucosal plexus. It was stronger in the diabetes group than in the normal group (no staining neurons% 6.2 ± 0.2 vs 0.3 ± 0.04, mild 14.9 ± 2.1 vs 17.6 ± 1.5, moderate 53.1 ± 4.6 vs 44.7 ± 4.4, strong 25.6 ± 18 vs 43.6 ± 4.0, P < 0.05). In the rectum, RAGE was primarily found in the mucosa epithelial cells.
CONCLUSION: The AGE and RAGE expression was up-regulated in the GI tract of GK diabetic rats and may contribute to GI dysfunction in type 2 diabetic patients.

Entities:  

Keywords:  Advanced glycation end products; Diabetes mellitus; Gastrointestinal complications; Receptor of advanced glycation end products

Year:  2015        PMID: 25987965      PMCID: PMC4434088          DOI: 10.4239/wjd.v6.i4.662

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  44 in total

1.  The role of glycation cross-links in diabetic vascular stiffening.

Authors:  T J Sims; L M Rasmussen; H Oxlund; A J Bailey
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

2.  Up-regulated expression of advanced glycation end-products and their receptor in the small intestine and colon of diabetic rats.

Authors:  Pengmin Chen; Jingbo Zhao; Hans Gregersen
Journal:  Dig Dis Sci       Date:  2011-11-06       Impact factor: 3.199

3.  Irbesartan inhibits advanced glycation end product (AGE)-induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) mRNA levels in glomerular endothelial cells.

Authors:  Takanori Matsui; Yuri Nishino; Sayaka Maeda; Masayoshi Takeuchi; Sho-ichi Yamagishi
Journal:  Microvasc Res       Date:  2011-01-12       Impact factor: 3.514

4.  A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus.

Authors:  Hirohiko Iwasaki; Masayoshi Kajimura; Satoshi Osawa; Shigeru Kanaoka; Takahisa Furuta; Mutsuhiro Ikuma; Akira Hishida
Journal:  J Gastroenterol       Date:  2006-12-08       Impact factor: 7.527

5.  Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection.

Authors:  Friedemann Reber; Romy Geffarth; Michael Kasper; Andreas Reichenbach; Erwin D Schleicher; Axel Siegner; Richard H W Funk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-07       Impact factor: 3.117

6.  Biomechanical and histomorphometric colon remodelling in STZ-induced diabetic rats.

Authors:  Jingbo Zhao; Toshiya Nakaguchi; Hans Gregersen
Journal:  Dig Dis Sci       Date:  2008-11-07       Impact factor: 3.199

7.  The intestinal brush border membrane in diabetes. Studies of sucrase-isomaltase metabolism in rats with streptozotocin diabetes.

Authors:  W A Olsen; H Korsmo
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

8.  Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice.

Authors:  Jan M Nielsen; Steen B Kristiansen; Rikke Nørregaard; Claus L Andersen; Larry Denner; Torsten T Nielsen; Allan Flyvbjerg; Hans E Bøtker
Journal:  Eur J Heart Fail       Date:  2009-06-05       Impact factor: 15.534

Review 9.  Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide.

Authors:  Nicolas Grossin; Marie-Paule Wautier; Jean-Luc Wautier
Journal:  Biorheology       Date:  2009       Impact factor: 1.875

10.  The prevalence of gastrointestinal symptoms in patients with non-insulin dependent diabetes mellitus.

Authors:  Jung-Hwan Oh; Myung-Gyu Choi; Moo-Il Kang; Kang-Moon Lee; Jin Il Kim; Byung-Wook Kim; Dong-Soo Lee; Sung-Soo Kim; Hwang Choi; Sok-Won Han; Kyu-Yong Choi; Ho-Young Son; In-Sik Chung
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 2.884

View more
  9 in total

1.  Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.

Authors:  C M Rosa; R Gimenes; D H S Campos; G N Guirado; C Gimenes; A A H Fernandes; A C Cicogna; R M Queiroz; I Falcão-Pires; D Miranda-Silva; P Rodrigues; F R Laurindo; D C Fernandes; C R Correa; M P Okoshi; K Okoshi
Journal:  Cardiovasc Diabetol       Date:  2016-09-01       Impact factor: 9.951

2.  Transcriptomic Profiling of High-Density Giardia Foci Encysting in the Murine Proximal Intestine.

Authors:  Jonathan K Pham; Christopher Nosala; Erica Y Scott; Kristofer F Nguyen; Kari D Hagen; Hannah N Starcevich; Scott C Dawson
Journal:  Front Cell Infect Microbiol       Date:  2017-05-31       Impact factor: 5.293

Review 3.  Diabetes-induced mechanophysiological changes in the small intestine and colon.

Authors:  Mirabella Zhao; Donghua Liao; Jingbo Zhao
Journal:  World J Diabetes       Date:  2017-06-15

4.  Tangshen Formula Attenuates Colonic Structure Remodeling in Type 2 Diabetic Rats.

Authors:  Pengmin Chen; Jingbo Zhao; Haojun Zhang; Xin Yang; Tingting Zhao; Huicun Zhang; Meihua Yan; Lin Pan; Xin Li; Yun Zhang; Ping Li
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-20       Impact factor: 2.629

5.  Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes.

Authors:  Yifeng Wang; Licheng Ding; Jiayue Yang; Lijun Liu; Liang Dong
Journal:  PeerJ       Date:  2021-02-02       Impact factor: 2.984

Review 6.  The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes.

Authors:  Matthew Snelson; Elisa Lucut; Melinda T Coughlan
Journal:  Int J Mol Sci       Date:  2022-02-03       Impact factor: 5.923

Review 7.  A short review on the features of the non-obese diabetic Goto-Kakizaki rat intestine.

Authors:  G M Gimenes; G O Santana; M V M Scervino; R Curi; J N B Pereira
Journal:  Braz J Med Biol Res       Date:  2022-08-22       Impact factor: 2.904

8.  Mechanism Investigation of the Improvement of Chang Run Tong on the Colonic Remodeling in Streptozotocin-Induced Diabetic Rats.

Authors:  Hong Sha; Dong Zhao; Xiaolin Tong; Hans Gregersen; Jingbo Zhao
Journal:  J Diabetes Res       Date:  2015-12-28       Impact factor: 4.011

9.  Abnormal expressions of AGEs, TGF-β1, BDNF and their receptors in diabetic rat colon-Associations with colonic morphometric and biomechanical remodeling.

Authors:  Hong Sha; Xiaolin Tong; Jingbo Zhao
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.